Metraipolis › archive › dc_c5352c2bc5ca

An international, multicentre, interventional, randomised, assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active… — Europe PMC PMID:41872937

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41872937
DOI
10.1186/s13063-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-04T01:42:17.722Z
SHA-256 of the archived text
d25db0c7f760f23dbd342a58271b7a3d38f83d033a101eb257d3a06dc147f7cc
Stable URL of this page
https://metraipolis.com/documento/dc_c5352c2bc5ca

How to cite

An international, multicentre, interventional, randomised, assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active… — Europe PMC PMID:41872937 — Europe PMC (en), https://europepmc.org/article/MED/41872937 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c5352c2bc5ca (Metraipolis archive dc_c5352c2bc5ca, sha256 d25db0c7f760f23dbd342a58271b7a3d38f83d033a101eb257d3a06dc147f7cc)
BibTeX
@misc{dcc5352c2bc5ca,
  title = {An international, multicentre, interventional, randomised, assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active… — Europe PMC PMID:41872937},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41872937},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c5352c2bc5ca; sha256 d25db0c7f760f23dbd342a58271b7a3d38f83d033a101eb257d3a06dc147f7cc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41872937. Agents can read the archived copy with the MCP tool read_document.